US6927212B2ExpiredUtilityA1
Design and synthesis of renal dipeptidase inhibitors
Est. expiryJul 27, 2022(expired)· nominal 20-yr term from priority
C07F 9/303C07B 2200/05C07B 59/004A61K 51/0489
64
PatentIndex Score
4
Cited by
4
References
8
Claims
Abstract
Aminophosphinic acid derivatives were synthesized as potential inhibitors of renal dipeptidase, an enzyme overexpressed in benign and malignant colon tumors. Several compounds showed potent enzyme-inhibitory activity. These compounds can be used therapeutically and diagnostically for treatment and detection of tumors.
Claims
exact text as granted — not AI-modified1. A compound of formula I:
wherein
X is selected from the group consisting of F, Cl, Br, 125 I, I, CF 3 , NR′, and radioisotopes thereof;
Y is selected from the group consisting of H, CH 3 , OCH 3 , CF 3 , F, Cl, 125 I, NR′, and radioisotopes thereof;
NR′ is selected from NH 2 , N(C1 to C6 alkyl) 2 , and NH (C1 to C6 alkyl);
Z is selected from the group consisting of O, S, and radioisotopes thereof.
2. The compound of claim 1 which is the E isoform.
3. The compound of claim 1 which is the Z isoform.
4. The compound of claim 1 which is radiolabeled.
5. The compound of claim 1 wherein at least one atom of X or Y is radiolabeled.
6. The compound of claim 1 wherein at least one of X or Y is an 125 I atom.
7. A sterile, apyrogenic formulation for intravenous administration to a human subject comprising:
the compound of claim 1 ; and
water.
8. The method of inhibiting colon tumor growth, comprising:
administering to a subject carrying a colon tumor an effective amount of a compound of claim 1 , whereby growth of the colon tumor is inhibited.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.